Results 71 to 80 of about 1,245 (197)

Quantitative Assessment of Whole-Body Tumor Burden in Adult Patients with Neurofibromatosis [PDF]

, 2012
Patients with neurofibromatosis 1 (NF1), NF2, and schwannomatosis are at risk for multiple nerve sheath tumors and premature mortality. Traditional magnetic resonance imaging (MRI) has limited ability to assess disease burden accurately.
Alona Muzikansky, Ara Kassarjian, BL Wu, CE Clauser, Conference NIH Consensus, DG Evans, DJ Waggoner, E Sbidian, FC Yang, G Deltas, G Otsuka, GA Rouleau, Gordon J. Harris, JA Biegel, JA Trofatter, JH Tonsgard, JJ Mulvihill, JM Friedman, K Cichowski, K North, Karl Herholz, KS Vogel, L Dugoff, Lance L. Munn, M Aghi, M Curto, M Giovannini, M Lammert, M MacCollin, M Ruggieri, M Upadhyaya, Manor Askenazi, ME Baser, ME Baser, ME McLaughlin, Miriam A. Bredella, Ralph Wenzel, RM Cawthon, Rosa Nguyen, SA Rasmussen, Scott R. Plotkin, SM Huson, Sonia Esparza, T Jacks, T Tucker, TA Duong, TJ Hulsebos, Vanessa L. Merker, VF Mautner, VF Mautner, Victor F. Mautner, W Cai, W Li, Wenli Cai   +53 more
core   +3 more sources

Reporte de familias con neurofibromatosis y otras enfermedades genéticas Reports of families suffering from neurofibromatosis and other genetic disorders

Revista de Ciencias Médicas de Pinar del Río, 2011
La neurofibromatosis tipo 1, es una enfermedad genética que primariamente afecta el desarrollo y crecimiento celular del sistema nervioso, clínicamente se caracteriza por máculas café con leche, neurofibromas, pecas en regiones no expuestas al sol ...
Miladys Orraca Castillo, Deysi Licourt Otero, Ana Isabel Sánchez Álvarez de La Campa   +2 more
doaj  

Neurofibroma solitario en pared abdominal en paciente sin neurofibromatosis: reporte de caso

Biomédica: revista del Instituto Nacional de Salud, 2009
Introducción. Los neurofibromas solitarios son tumores benignos de carácter hereditario, que presentan variantes. Las manifestaciones clínicas cambian según su localización y, ocasionalmente, son similares a las de la neurofibromatosis.
Juan Sebastián Barajas, Ludwing Flórez Salamanca   +1 more
doaj   +1 more source

Asymmetry of thalamic hypometabolism on FDG‐PET/CT in neurofibromatosis type 1: Association with peripheral tumor burden

Journal of Neuroimaging, Volume 34, Issue 1, Page 138-144, January/February 2024.
Abstract Background and Purpose Thalamic hypometabolism is a consistent finding in brain PET with F‐18 fluorodeoxyglucose (FDG) in patients with neurofibromatosis type 1 (NF1). However, the pathophysiology of this metabolic alteration is unknown. We hypothesized that it might be secondary to disturbance of peripheral input to the thalamus by NF1 ...
Cansu Özden, Victor‐Felix Mautner, Said Farschtschi, Isabel Molwitz, Inka Ristow, Peter Bannas, Lennart Well, Susanne Klutmann, Gerhard Adam, Ivayla Apostolova, Ralph Buchert   +10 more
wiley   +1 more source

A diagnostic approach to neurocutaneous syndromes

Arquivos de Neuro-Psiquiatria
Neurocutaneous syndromes are a group of genetically and phenotypically diverse disorders that primarily affect the skin, central and peripheral nervous systems, and eyes.
Sofia Mônaco Gama, João Vitor Gerdulli Tamanini, Marianna Pinheiro Moraes de Moraes, Thiago Yoshinaga Tonholo Silva, Fernanda Teresa de Lima, José Luiz Pedroso, Orlando Graziani Povoas Barsottini   +6 more
doaj   +1 more source

Une tumeur maligne des gaines des nerfs périphériques compliquant la maladie de Von Recklinghausen [PDF]

, 2016
Les tumeurs malignes des gaines des nerfs périphériques ou MPNST (Malign Peripheral Nerve Sheath Tumors selon les anglo-saxons) sont des tumeurs rares qui constituent la principale complication des neurofibromatoses de type 1 (NF1) à l'âge adulte.
Abbassi, A.E., Gharib, N, Hajjad, T, Mazouz, S.E.   +3 more
core   +2 more sources

A Case of Atypical Neurofibromatous Neoplasm of Uncertain Biologic Potential: Unravelling the Enigma [PDF]

Journal of Clinical and Diagnostic Research
Neurofibromatoses are a group of genetic disorders that cause tumours to form on the nerve tissue. These tumours can progress to more proliferative lesions and can also eventually become malignant, giving rise to a Malignant Peripheral Nerve Sheath ...
Apoorva Pande, Samarth Shukla, Sourya Acharya, Pravin Gadkari, Milind Pande   +4 more
doaj   +1 more source

Characterization and utilization of an international neurofibromatosis web-based, patient-entered registry: An observational study.

PLoS ONE, 2017
The neurofibromatoses (neurofibromatosis type 1, neurofibromatosis type 2 and schwannomatosis) are rare disorders having clinical manifestations that vary greatly from patient to patient.
Mindell Seidlin, Robert Holzman, Pamela Knight, Bruce Korf, Vanessa Rangel Miller, David Viskochil, Annette Bakker, Children’s Tumor Foundation   +7 more
doaj   +1 more source

Therapeutic Development in Neurofibromatosis [PDF]

, 2019
Although neurofibromatosis (NF) was initially recognized in the nineteenth century, only in the past two decades we have witnessed a paradigm shift in therapeutics.
Korf, Bruce R., Lobbous, Mina
core   +1 more source

FEOCROMOCITOMA E NEUROFIBROMATOSE 1

Revista da Sociedade Portuguesa de Dermatologia e Venereologia, 2014
Introdução: Feocromocitomas são tumores originários de células cromafins do sistema simpato-adrenal. As suas manifestações clínicas são múltiplas e diversificadas, função do perfil secretório variável de múltiplos compostos, incluindo catecolaminas ...
Rui Tavares-Bello, Mafalda Marcelino, Ema L. Nobre, Luís Lopes, Carlos Lopes, João Jácome de Castro   +5 more
doaj   +1 more source